Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
Superinvestors holding ALVOW, Q2 2026
1 superinvestor reports holding Alvotech on Form 13F, worth $1.07M in total. Weight is Alvotech's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Oaktree CapitalHoward Marks | <0.1% | 4,666,667 | $1.07M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ALVOW each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2022
1 superinvestor holding at quarter end